Publications by authors named "Oliver Burn"

Claim this Profile
M
Methods for Estimating Long-Term Outcomes for Trastuzumab Deruxtecan in HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies.
Kyle Dunton, Gerard Vondeling, Elizabeth Hancock, Margaret Petrou, Oliver Burn

Target Oncolยท November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis